Editorial: Safety, Efficacy and Mechanisms of Action of Mesenchymal Stem Cell Therapies.
作者信息
Moll Guido, Hoogduijn Martin J, Ankrum James A
机构信息
BIH Center for Regenerative Therapies (BCRT), Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health (BIH), Berlin, Germany.
Nephrology and Transplantation, Department of Internal Medicine, Erasmus MC, University Medical Center, Rotterdam, Netherlands.
出版信息
Front Immunol. 2020 Feb 18;11:243. doi: 10.3389/fimmu.2020.00243. eCollection 2020.
Abstract
摘要
相似文献
1
Editorial: Safety, Efficacy and Mechanisms of Action of Mesenchymal Stem Cell Therapies.社论：间充质干细胞疗法的安全性、有效性及作用机制
Front Immunol. 2020 Feb 18;11:243. doi: 10.3389/fimmu.2020.00243. eCollection 2020.
2
MSCs-cells with many sides.间充质干细胞——具有多面性的细胞。
Cytotherapy. 2018 Mar;20(3):273-278. doi: 10.1016/j.jcyt.2018.01.009. Epub 2018 Feb 9.
3
MSCs in hematopoietic cell transplantation.造血细胞移植中的间充质干细胞。
Biol Blood Marrow Transplant. 2011 Jan;17(1 Suppl):S21-9. doi: 10.1016/j.bbmt.2010.11.026.
4
Therapeutic applications of mesenchymal stem cells to repair kidney injury.间充质干细胞治疗肾脏损伤的应用。
J Urol. 2010 Jul;184(1):26-33. doi: 10.1016/j.juro.2010.03.050. Epub 2010 May 15.
5
Mesenchymal stromal cell therapy in liver disease: opportunities and lessons to be learnt?间充质基质细胞疗法在肝脏疾病中的应用：机遇与教训？
Am J Physiol Gastrointest Liver Physiol. 2015 Nov 15;309(10):G791-800. doi: 10.1152/ajpgi.00036.2015. Epub 2015 Aug 27.
6
Emerging understanding of apoptosis in mediating mesenchymal stem cell therapy.凋亡在介导间充质干细胞治疗中的作用的新认识。
Cell Death Dis. 2021 Jun 9;12(6):596. doi: 10.1038/s41419-021-03883-6.
7
Mesenchymal Stem Cells for the Treatment of Liver Disease: Present and Perspectives.间充质干细胞治疗肝脏疾病：现状与展望。
Gut Liver. 2020 May 15;14(3):306-315. doi: 10.5009/gnl18412.
8
Intravascular Mesenchymal Stromal/Stem Cell Therapy Product Diversification: Time for New Clinical Guidelines.血管内间充质基质/干细胞治疗产品多样化：是时候制定新的临床指南了。
Trends Mol Med. 2019 Feb;25(2):149-163. doi: 10.1016/j.molmed.2018.12.006. Epub 2019 Jan 30.
9
Improving outcome of transplanted mesenchymal stem cells for ischemic heart disease.改善间充质干细胞移植治疗缺血性心脏病的疗效。
Biochem Biophys Res Commun. 2008 Nov 14;376(2):247-50. doi: 10.1016/j.bbrc.2008.09.004. Epub 2008 Sep 19.
10
Mesenchymal stem cell therapy of intestinal disease: are their effects systemic or localized?间质干细胞治疗肠道疾病：其作用是全身性的还是局部性的？
Curr Opin Gastroenterol. 2011 Mar;27(2):119-24. doi: 10.1097/MOG.0b013e3283423f20.
引用本文的文献
1
Advanced nanotherapies for precision treatment of inflammatory lung diseases.用于炎症性肺病精准治疗的先进纳米疗法。
Bioact Mater. 2025 Jul 20;53:329-365. doi: 10.1016/j.bioactmat.2025.07.028. eCollection 2025 Nov.
2
Key mediators of the efficacy of mesenchymal stem cells on disease models.间充质干细胞对疾病模型疗效的关键介质。
Cell Transplant. 2025 Jan-Dec;34:9636897251348566. doi: 10.1177/09636897251348566. Epub 2025 Jun 25.
3
Definition of Synovial Mesenchymal Stem Cells for Meniscus Regeneration by the Mechanism of Action and General Amp1200 Gene Expression.基于作用机制和通用 Amp1200 基因表达定义半月板再生的滑膜间充质干细胞。
Int J Mol Sci. 2024 Sep 29;25(19):10510. doi: 10.3390/ijms251910510.
4
Specific Features of the Functional Activity of Human Adipose Stromal Cells in the Structure of a Partial Skin-Equivalent.人脂肪基质细胞在部分皮肤等效物结构中的功能活性的特定特征。
Int J Mol Sci. 2024 Jun 7;25(12):6290. doi: 10.3390/ijms25126290.
5
Polish regulatory system regarding ATMP hospital exemptions.波兰关于 ATMP 医院豁免的监管体系。
Front Immunol. 2024 May 13;15:1379134. doi: 10.3389/fimmu.2024.1379134. eCollection 2024.
6
Mesenchymal stromal cells plus basiliximab improve the response of steroid-refractory acute graft-versus-host disease as a second-line therapy: a multicentre, randomized, controlled trial.间充质基质细胞加巴利昔单抗作为二线治疗改善激素难治性急性移植物抗宿主病的反应：一项多中心、随机、对照试验。
BMC Med. 2024 Feb 27;22(1):85. doi: 10.1186/s12916-024-03275-5.
7
The MSC-EV-microRNAome: A Perspective on Therapeutic Mechanisms of Action in Sepsis and ARDS.MSC-EV 微小 RNA 组学：脓毒症和 ARDS 治疗作用机制的新视角。
Cells. 2024 Jan 9;13(2):122. doi: 10.3390/cells13020122.
8
Recent Advances in Mesenchymal Stem/Stromal Cell-Based Therapy for Alcohol-Associated Liver Disease and Non-alcoholic Fatty Liver Disease.间质干细胞/基质细胞治疗酒精相关性肝病和非酒精性脂肪性肝病的最新进展。
Stem Cells Transl Med. 2024 Feb 14;13(2):107-115. doi: 10.1093/stcltm/szad082.
9
An optimized procedure for preparation of conditioned medium from Wharton's jelly mesenchymal stromal cells isolated from umbilical cord.一种用于制备从脐带分离的沃顿胶间充质基质细胞条件培养基的优化方法。
Front Mol Biosci. 2023 Oct 2;10:1273814. doi: 10.3389/fmolb.2023.1273814. eCollection 2023.
10
Apoptosis in mesenchymal stromal cells activates an immunosuppressive secretome predicting clinical response in Crohn's disease.间充质基质细胞中的细胞凋亡激活了一种免疫抑制分泌组，可预测克罗恩病的临床反应。
Mol Ther. 2023 Dec 6;31(12):3531-3544. doi: 10.1016/j.ymthe.2023.10.004. Epub 2023 Oct 7.
本文引用的文献
1
Mesenchymal stem cell perspective: cell biology to clinical progress.间充质干细胞展望：从细胞生物学到临床进展
NPJ Regen Med. 2019 Dec 2;4:22. doi: 10.1038/s41536-019-0083-6. eCollection 2019.
2
Mesenchymal Stromal Cells Anno 2019: Dawn of the Therapeutic Era? Concise Review.间质基质细胞 2019 年：治疗时代的曙光？简明综述。
Stem Cells Transl Med. 2019 Nov;8(11):1126-1134. doi: 10.1002/sctm.19-0073. Epub 2019 Jul 7.
3
Convergence of Cell Pharmacology and Drug Delivery.细胞药理学与药物输送的融合
Stem Cells Transl Med. 2019 Sep;8(9):874-879. doi: 10.1002/sctm.19-0019. Epub 2019 May 15.
4
Biomanufacturing for clinically advanced cell therapies.临床先进细胞疗法的生物制造。
Nat Biomed Eng. 2018 Jun;2(6):362-376. doi: 10.1038/s41551-018-0246-6. Epub 2018 Jun 11.
5
Manufacturing of primed mesenchymal stromal cells for therapy.为治疗而制备的间充质基质细胞。
Nat Biomed Eng. 2019 Feb;3(2):90-104. doi: 10.1038/s41551-018-0325-8. Epub 2019 Jan 28.
6
Challenges for mesenchymal stromal cell therapies.间充质基质细胞治疗的挑战。
Sci Transl Med. 2019 Feb 20;11(480). doi: 10.1126/scitranslmed.aat2189.
7
Intravascular Mesenchymal Stromal/Stem Cell Therapy Product Diversification: Time for New Clinical Guidelines.血管内间充质基质/干细胞治疗产品多样化：是时候制定新的临床指南了。
Trends Mol Med. 2019 Feb;25(2):149-163. doi: 10.1016/j.molmed.2018.12.006. Epub 2019 Jan 30.
8
Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases.间充质干细胞和基质细胞在炎症性疾病中的免疫调节机制。
Nat Rev Nephrol. 2018 Aug;14(8):493-507. doi: 10.1038/s41581-018-0023-5.
9
Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities.间质基质细胞：临床挑战与治疗机遇。
Cell Stem Cell. 2018 Jun 1;22(6):824-833. doi: 10.1016/j.stem.2018.05.004.
10
Placenta-Derived Decidua Stromal Cells for Treatment of Severe Acute Graft-Versus-Host Disease.胎盘来源的蜕膜基质细胞治疗严重急性移植物抗宿主病。
Stem Cells Transl Med. 2018 Apr;7(4):325-331. doi: 10.1002/sctm.17-0167. Epub 2018 Mar 13.
Zotero 插件